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Abstract 
　　Cystinuria is known as a representative inherited metabolic disorder accompanied with mental retarda-
tion. We determined whether the amino acid transport into brain was impaired in a 13-month-old boy with seri-
ous developmental delay accompanied with cystinuria. Serum levels of cystine and arginine were 
decreased. On the other hand cystine and dibasic amino acids levels (ornithine, lysine and arginine) in cerebro-
spinal fluids were all within the normal range. Neurodevelopmental delay improved from DQ 79 to 106 except 
regarding movement (locomotion and hand exercise). A low level of serum arginine might influence brain and 
neuronal development.
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noticed. He was born after a normal pregnancy (41 
weeks and 4 days). His birthweight was 4,178 g, height 
52 cm, and head circumference 35 cm. He had throm-
bocythemia as a neonate (the details were not known). 
His uncle had had a renal stone. He held his head at 2 
months, sat alone at 5 months, and gripped objects at 7 
month of age. Neurodevelopmental delay was noticed 
at the age of 1 year. He could neither turn over, crawl, 
nor walk without support. Muscle tonus was decreased. 
DQ (Developmental Quotient) was 79 measured by the 
Enjoji infantile developmental assessments. On admis-
sion his physical examination results at the age of 13 
months were unremarkable. Facial dysmorphism and 
anomaly were not present. His laboratory findings 
(Table 1) showed no specific findings except for white 
blood cell counts. The results of examinations for 
TORCH syndrome were negative. Urinalysis, head CT, 
abdominal echogram and fundus examination revealed 
no irregularities.
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Introduction
　Cystinuria is known as a representative inherited meta-
bolic disorder with mental retardation1-3). One in 5-20% 
of such patients with cystinuria are mentally retarded, 
with an IQ below 704). Pathological correlation between 
cystinuria and neurological conditions is still undeter-
mined. The amino acid transport into the brain is 
regarded to be impaired, as in the kidney and gastrointes-
tinal tract1). Blasberg et al emphasized the similarity 
between amino acid transportation into the brain and the 
kidney5). However, the reason for this is unknown. 
We investigated whether the amino acid transport in 
cerebrospinal fluid was impaired in a patient with serious 
developmental delay and cystinuria.
Case report
　A 13-month-old boy was admitted because of pneu-
monia. On admission developmental delay was 
Clinical report
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Table 1  Laboratory findings at the age of 13 months
WBC /μl 16,900↑ ASLO IU/ml <60
RBC 104/μl 506 IgG mg/dl 1,250
Hb g/dl 12.7 IgA mg/dl 116
Ht % 39.0 IgM mg/dl 268
PLt /μl 13.9 IgE IU/ml 102
AST U/l 31 C3 mg/dl 116
ALT U/l 11 C4 mg/dl  40
TP g/dl 7.7 CH50 U/ml  54.7
T-Bil mg/dl 0.51
D-Bil mg/dl 0.1 Rubella IgM (FA) (－)
I-Bil mg/dl 0.41 Rubella (HI) (－)
BUN mg/dl 5.1 HSV-IgM(FA) (－)
Creatinin mg/dl 0.2 CMV-IgM (FA) (－)
Glucose mg/dl 109 Toxoplasma IgG (－)
Na mEq/l 143 Toxoplasma IgM (－)
Cl mEq/l 106 Toxoplasma IgM (－)
K mEq/l 3.8
CRP mg/dl <0.3
CPK u/l 46
Table 2 Analysis of amino acids
samples age unit cystine ornithine lysine arginine tryptophan
urine 13 months μmol/day 370.2 ↑
 (20-200)
  338.2 ↑
(7-50)
  3493.8 ↑
(7-50)
172.2 ↑
(10-60)
 47.8
(20-150)
urine
(one point in a day)
18 months μmol/day 2064.1 ↑
(20-200)
1046.3 ↑
(7-50)
14186.6 ↑
(7-50)
655.0 ↑
(10-60)
204.7 ↑
(20-150)
plasma 24 months nmol/mL     20.8 ↓
(29-49)
 70.9
(30-100)
170.9
(110-240)
  47.4 ↓
(54-130)
 64.3
(37-75)
cerebrospinal fluid 24 months nmol/mL ND
(ND)
 4.5
(2.84-19.17)
 20.6
(11.61-36.47)
15
(11.92-31.0)
ND
(ND)
(  ) mean normal range.  The control cerebrospinal fluids were obtained from patients without any CNS diseases.
Other amino acids were all within normal ranges
 - 1 - 
Figure 1: The developmental quotient (DQ) were assessed by the Enjoji method (%) 
0
20
40
60
80
100
120
140
locomotion hand exercise common
practice
human
interaction
speech language
comprehension
DQ
13 months
15 months
24 months
 Fig. 1　The developmental quotient (DQ) were assessed by the Enjoji method (%)
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　Analysis of amino acids showed extremely high levels 
of cystine and dibasic amino acids (ornithine, lysine and 
arginine) in excreted urine. Serum levels of cystine and 
arginine were decreased to 20.8 (29-49) and 47.4 (54-
130), respectively. On the other hand cystine and diba-
sic amino acids (ornithine, lysine and arginine) in cere-
brospinal fluids were all within normal limits, which are 
shown in Table 2. Neurodevelopmental delay improved 
from DQ 79 to 106 except for movements (locomotion 
and hand exercise), as listed in Figure 1.
Discussion
　Cystinuria is classified into three types as type 1 and 
non-type 1, which is also classified into type II and III 
according to the abnormality of absorption in the intesti-
nal epithelium6,7). Since serum levels of cystine and 
arginine in this report were decreased, his disease was 
classified as type I. Type I cystinuria is known to be 
caused by a mutation in SLC3A1, located on chromo-
some 2p-16.3-21 eoncoding rBAT (related to B0,+ amino 
acid transporter)8). Unfortunately we could not investi-
gate his genome including amino acids. However, his 
family history suggested homozygous or double hetero 
mutation of rBAT6,9). 
　Cystinuria is known as a representative inherited meta-
bolic disorder with mental retardation and multi-system 
disorder including nephrolithiasis 10-12). Impairment of 
amino acid transport into the brain is seems to cause 
mental retardation. However, the levels of amino acid 
including cystine and dibasic amino acids in cerebrospi-
nal  f luid were within the normal range in this 
case. Therefore impairment of amino acid transport 
into the brain did not directly cause his developmental 
delay.
　The location of rBAT is distributed in the brain, kidney 
and intestine13) and the impairment of cell membranes in 
neurons and glial cells might occur. Alternatively his 
plasma arginine level was lower than in normal 
cases. Arginine is a conditionally nonessential amino 
acid, meaning most of the time it can be manufactured by 
the human body, and does not need to be obtained 
directly through diet in adults. However, in infants the 
process of the synthesis of arginine is not mature. 
Therefore a lack of arginine might influence the develop-
ment of brain and neuron, because arginine works as a 
precursor of nitric oxide (NO). NO from nNOS is a 
representative neurotransmitter. Alternatively low argi-
nine might induce hyperammonemia, as was been 
reported in experimental models14).
　This is apparently the first report on amino acid in 
cerebrospinal fluid in a patient with cystinuria.
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発達遅延を伴うシスチン尿症における正常脳内アミノ酸トランスポート
河　島　尚　志　　　天　羽　将　博　　　西　亦　繁　雄 
柏　木　保　代　　　武　隈　孝　治　　　星　加　明　徳
東京医科大学小児科学講座
　シスチン尿症は発達遅延を伴う遺伝的な代謝異常の代表として知られている。今回、シスチン尿症に発育遅延を
伴う 13か月児において、アミノ酸輸送が正常であるかを検討した。血中のシスチンとアルギニンの値は減少してい
た。シスチンとアルギニンの血中濃度は減少していたが、髄液中の 2塩基アミノ酸（オルニチン、リジンおよびア
ルギニン）はコントロールと比較し、正常域であった。患児の発達は運動（移動および手運動）を除いて成長とと
もに 79から 106と改善が認めたことから、乳幼児期の血中のアルギニンが低いことが脳や神経の発達の影響してい
た可能性が推察された。
〈キーワード〉　シスチン尿症、発達遅延、小児、血液脳関門、二塩基性アミノ酸
